Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM(2019) A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases Transl Oncol, 12(7), 951-958 DOI 10.1016/j.tranon.2019.04.001, PubMed 31096111
Njølstad PR, Andreassen OA, Brunak S, Børglum AD, Dillner J, Esko T, Franks PW, Freimer N, Groop L, Heimer H, Hougaard DM, Hovig E, Hveem K, Jalanko A, Kaprio J, Knudsen GP, Melbye M, Metspalu A, Mortensen PB, Palmgren J, Palotie A, Reed W, Stefánsson H, Stitziel NO, Sullivan PFet al.(2019) Roadmap for a precision-medicine initiative in the Nordic region Nat Genet, 51(6), 924-930 DOI 10.1038/s41588-019-0391-1, PubMed 30988515
Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group(2019) International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation Br J Cancer(in press) DOI 10.1038/s41416-019-0446-1, PubMed 30971774